Charter
The Process and Product Development Subcommittee strives to:
- Establish and communicate best practices in Process and Product Development (PPD) as it relates to therapeutic cell based products.
- Assess emerging cell processing technologies and forecast their impact on the commercialization process.
Click here to view the full charter.
Projects and Objectives
- Educational Webinars: Process Development is a discipline learned on the job and there are few texts that cover many of the best practices used in the field—and fewer available that discuss Cell Therapy-specific requirements. The Process and Product Development Subcommittee develops educational webinars to cover best practices in Cell Therapy Process Development. Click here to view upcoming webinars.
- White papers: White papers are an important vehicle for the PPD to educate and influence the field. White papers will be published in peer-reviewed journals to increase credibility and visibility of the PPD and ISCT. Click here to view the published PPD white papers.
- ISCT Annual Meeting: The PPD will be actively involved in the organization of the ISCT Annual Meeting. At least one session in the Strategies for Commercialization Track will be organized by this committee.

Committee Chair
.jpg)
|
Ohad Karnieli, PhD, MBA
Chair
Karnieli Inc.
Haifa, Israel
|
Committee Members
Eytan Abraham, PhD
Lonza
Walkersville, MA, United States
|
Julie Allickson, PhD, MSc, MT(ASCP)
Wake Forest Institute for Regenerative Medicine
Winston-Salem, NC, United States |
Myriam Armant, PhD
Harvard Stem Cell Institute
Boston, MA, United States
|
Thierry Bovy
Pall Life Sciences
Dreieich, Germany
|
Harvey Brandwein, PhD
Cook Regentec
Port Washington, NY, United States
|
Christopher Bravery, PhD
Advanced Biologicals Ltd.
London, United Kingdom
|
Thomas Brieva, PhD
Celgene Cellular Therapeutics
Warren, MI, United States
|
Scott Burger, MD
Advanced Cell & Gene Therapy
Chapel Hill, NC, United States |
Sarah Callens
Cell and Gene Therapy Catapult
London, UK
|
Frank Fischer
Cook Regentec
Bloomington, IN, United States
|
Dominic Clarke, PhD
Charter Medical
Winston-Salem, NC, United States
|
Shannon Eaker, PhD
GE Healthcare
Knoxville, TN, United States
|
John Fink, MBA
Brooks Life Science Systems
Chelmsford, MA, United States
|
David Fiorentini, MSc
Biological Industries
Kibbutz Beit-Haemek, Israel
|
Mark Leonard
Pfizer
Andover, MA, United States
|
Michael Mendicino, PhD
Hybrid Concepts International, LLC
Grand Island, NY, United States
|
Kim Nguyen
Terumo BCT
Lakewood, CO, United States
|
Steve Oh, PhD
ASTAR
Singapore
|
Jean-Sébastien Parisse
Asceptic Technologies
Isnes, Belgium
|
Alaina Schlinker, PhD
Fresenius Kabi
Lake Zurich, IL, United States
|
Brad Shirley, MSc
Cook Regentec
Indianapolis, IN, United States
|
Ravenska Wagey, PhD
STEMCELL Technologies
Vancouver, BC, Canada
|
Amy Wehn, PhD
HTG Molecular Diagnostics
Raleigh-Durham, NC, United States
|
Maya Fuerstenau-Sharp, MS, PhD
Sartorius Stedim Biotech
Kassel Area, Germany |
Charles Golightly, MS, PhD
Pall Corporation
New York City, NY, United States |
Erik Woods, PhD
Ossium Health Inc.
Indianapolis, IN, United States
|
Andrew Campbell, PhD
Thermo Fisher Scientific
Buffalo/ Niagara, NY, United States
|
Knut Niss, PhD
MustangBio
Boston, MA, United States
|
|
|
|
Jean-Sébastien Parisse
Asceptic Technologies
Isnes, Belgium |
|